Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 2, Issue 18
September 25 2018
Issue Cover

Table of Contents

BLOOD ADVANCES TALK

Geriatric assessment in acute myeloid leukemia: current and future landscape
Kah Poh Loh,Heidi D. Klepin
View Articletitled, Geriatric assessment in acute myeloid leukemia: current and future landscape
Supplemental data

EXCEPTIONAL CASE REPORT

Phenotype description and response to thrombopoietin receptor agonist in DIAPH1-related disorder
Clinical Trials & Observations
Sarah K. Westbury,Kate Downes,Claire Burney,Maria L. Lozano,Samya G. Obaji,Cheng Hock Toh,Teresa Sevivas,Neil V. Morgan,Wendy N. Erber,Carly Kempster,Samantha F. Moore,Chantal Thys,Sofia Papadia,Willem H. Ouwehand,NIHR BioResource–Rare Diseases,Michael A. Laffan,Keith Gomez,Kathleen Freson,Jose Rivera,Andrew D. Mumford
View Articletitled, Phenotype description and response to thrombopoietin receptor agonist in <em>DIAPH1</em>-related disorder
Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

Increased acute care utilization in a prospective cohort of adults with sickle cell disease
Clinical Trials & Observations
Sophie Lanzkron,Jane Little,Joshua Field,Joseph Ryan Shows,Hang Wang,Rebecca Seufert,Jasmine Brooks,Ravi Varadhan,Carlton Haywood, Jr,Mustapha Saheed,Chiung Yu Huang,Brandi Griffin,Steven Frymark,Allie Piehet,Derek Robertson,Marc Proudford,Adrienne Kincaid,Charles Green,Lorri Burgess,Marcus Wallace,Jodi Segal
View Articletitled, Increased acute care utilization in a prospective cohort of adults with sickle cell disease

LYMPHOID NEOPLASIA

B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell–dominant T-cell responses via IL-33
Hiroshi Arima,Momoko Nishikori,Yasuyuki Otsuka,Wataru Kishimoto,Kiyotaka Izumi,Koubun Yasuda,Tomohiro Yoshimoto,Akifumi Takaori-Kondo
View Articletitled, B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell–dominant T-cell responses via IL-33
Supplemental data
Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group
Clinical Trials & Observations
Tao Wu,Yong Yang,Su-Yu Zhu,Mei Shi,Hang Su,Ying Wang,Xia He,Li-Ming Xu,Zhi-Yong Yuan,Li-Ling Zhang,Gang Wu,Bao-Lin Qu,Li-Ting Qian,Xiao-Rong Hou,Fu-Quan Zhang,Yu-Jing Zhang,Yuan Zhu,Jian-Zhong Cao,Sheng-Min Lan,Jun-Xin Wu,Chen Hu,Shu-Nan Qi,Bo Chen,Ye-Xiong Li
View Articletitled, Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group
Supplemental data
A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis
Clinical Trials & Observations
Julie Støve Bødker,Rasmus Froberg Brøndum,Alexander Schmitz,Anna Amanda Schönherz,Ditte Starberg Jespersen,Mads Sønderkær,Charles Vesteghem,Hanne Due,Caroline Holm Nørgaard,Martin Perez-Andres,Mehmet Kemal Samur,Faith Davies,Brian Walker,Charlotte Pawlyn,Martin Kaiser,David Johnson,Uta Bertsch,Annemiek Broyl,Mark van Duin,Rajen Shah,Preben Johansen,Martin Agge Nørgaard,Richard J. Samworth,Pieter Sonneveld,Hartmut Goldschmidt,Gareth J. Morgan,Alberto Orfao,Nikhil Munshi,Hans Erik Johnsen,Tarec El-Galaly,Karen Dybkær,Martin Bøgsted
View Articletitled, A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis
Supplemental data

MYELOID NEOPLASIA

Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells
Xiaoli Wang,Cing Siang Hu,Bruce Petersen,Jiajing Qiu,Fei Ye,Jane Houldsworth,Kevin Eng,Fei Huang,Ronald Hoffman
View Articletitled, Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells
Supplemental data

PLATELETS AND THROMBOPOIESIS

Rap1 binding to the talin 1 F0 domain makes a minimal contribution to murine platelet GPIIb-IIIa activation
Frederic Lagarrigue,Alexandre R. Gingras,David S. Paul,Andrew J. Valadez,Monica N. Cuevas,Hao Sun,Miguel A. Lopez-Ramirez,Benjamin T. Goult,Sanford J. Shattil,Wolfgang Bergmeier,Mark H. Ginsberg
View Articletitled, Rap1 binding to the talin 1 F0 domain makes a minimal contribution to murine platelet GPIIb-IIIa activation
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity
Ruqayyah J. Almizraq,Philip J. Norris,Heather Inglis,Somaang Menocha,Mathijs R. Wirtz,Nicole Juffermans,Suchitra Pandey,Philip C. Spinella,Jason P. Acker,Jennifer A. Muszynski
View Articletitled, Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity
Supplemental data

THROMBOSIS AND HEMOSTASIS

Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects
Constance C. F. M. J. Baaten,Frauke Swieringa,Tomasz Misztal,Tom G. Mastenbroek,Marion A. H. Feijge,Paul E. Bock,Marjo M. P. C. Donners,Peter W. Collins,Renhao Li,Paola E. J. van der Meijden,Johan W. M. Heemskerk
View Articletitled, Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects
Supplemental data
Engineered FVIII-expressing cytotoxic T cells target and kill FVIII-specific B cells in vitro and in vivo
Kalpana Parvathaneni,David W. Scott
View Articletitled, Engineered FVIII-expressing cytotoxic T cells target and kill FVIII-specific B cells in vitro and in vivo
Supplemental data
The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium
Thejaswi Kalagara,Tracy Moutsis,Yi Yang,Karin I. Pappelbaum,Anne Farken,Lucia Cladder-Micus,Sabine Vidal-y-Sy,Axel John,Alexander T. Bauer,Bruno M. Moerschbacher,Stefan W. Schneider,Christian Gorzelanny
View Articletitled, The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium
Supplemental data

TRANSPLANTATION

Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHD
Oleg V. Kolupaev,Trisha A. Dant,Hemamalini Bommiasamy,Danny W. Bruce,Kenneth A. Fowler,Stephen L. Tilley,Karen P. McKinnon,Stefanie Sarantopoulos,Bruce R. Blazar,James M. Coghill,Jonathan S. Serody
View Articletitled, Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHD
Supplemental data

VASCULAR BIOLOGY

Hematopoietic protease nexin-1 protects against lung injury by preventing thrombin signaling in mice
Deborah François,Véronique Arocas,Laurence Venisse,Karen Aymonnier,Leila Idir,Raphael Martos,Salome Gazit,Ludovic Couty,Martine Jandrot-Perrus,Eric Camerer,Yacine Boulaftali,Marie-Christine Bouton
View Articletitled, Hematopoietic protease nexin-1 protects against lung injury by preventing thrombin signaling in mice
Supplemental data
  • Cover Image

    Cover Image

    issue cover

    COVER FIGURE
    Representative immunofluorescence image of blood vessels adjacent to a murine malignant melanoma. Peritumoral blood vessels are positive for syndecan-1 (red) and von Willebrand factor (green). Cell nuclei are shown in blue. See the article by Kalagara et al.

  • PDF Icon PDF LinkFront Matter
  • PDF Icon PDF LinkEditorial Board
All Issues

Advertisement intended for health care professionals

American Society of Hematology: Building a Comprehensive Minority Recruitment and Retention Professional Program
A contemporary downtrend in chronic GVHD?
Imus PH, Pasca S, Tsai H-L, et al. Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies. Blood Adv. 2024;8(14):3849-3858.
Glisovic-Aplenc T, Diorio C, Chukinas JA, et al. CD38 as a pan-hematologic target for chimeric antigen receptor T cells. Blood Adv. 2023;7(16):4418-4430.
Sewastianik T, Jiang M, Sukhdeo K, et al. Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice. Blood Adv. 2017;1(25):2361-2374.

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals